Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (441-450 of 874) with videos related to

Pageof 88
Sort By:
The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.
AIDS (London, England)|November 14, 1998
Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, ZimbabweS Gregson, R Machekano, C A Donnelly, et al.
AIDS Research and Human Retroviruses|March 7, 2020
Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line TreatmentVinie Kouamou, Bhavini Varyani, Tinei Shamu, et al.
AIDS Research and Human Retroviruses|August 30, 2007
Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysisSeble Kassaye, Esther Lee, Rami Kantor, et al.
AIDS (London, England)|October 23, 2003
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenzRonald J Bosch, Gerald F Downey, David A Katzenstein, et al.
AIDS Research and Human Retroviruses|May 3, 2000
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamS Kim, M D Hughes, S M Hammer, et al.
Pediatric Blood & Cancer|July 10, 2009
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology GroupRebecka L Meyers, Jon R Rowland, Mark Krailo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllersLea Brandt, Thomas Benfield, Helene Mens, et al.
BMC Women'S Health|July 27, 2020
Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural ZimbabweMegan Fitzpatrick, Mythili P Pathipati, Kathy McCarty, et al.
Ugeskrift for Laeger|May 14, 2020
[Suspected toxoplasmosis in pregnancy]Mathilde Ørbæk, Anna Sophie L Kjær, Henrik V Nielsen, et al.
Pageof 88

Showing results (441-450 of 874) with videos related to

Sort By:
Pageof 88
The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.
AIDS (London, England)|November 14, 1998
Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, ZimbabweS Gregson, R Machekano, C A Donnelly, et al.
AIDS Research and Human Retroviruses|March 7, 2020
Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line TreatmentVinie Kouamou, Bhavini Varyani, Tinei Shamu, et al.
AIDS Research and Human Retroviruses|August 30, 2007
Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysisSeble Kassaye, Esther Lee, Rami Kantor, et al.
AIDS (London, England)|October 23, 2003
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenzRonald J Bosch, Gerald F Downey, David A Katzenstein, et al.
AIDS Research and Human Retroviruses|May 3, 2000
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamS Kim, M D Hughes, S M Hammer, et al.
Pediatric Blood & Cancer|July 10, 2009
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology GroupRebecka L Meyers, Jon R Rowland, Mark Krailo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllersLea Brandt, Thomas Benfield, Helene Mens, et al.
BMC Women'S Health|July 27, 2020
Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural ZimbabweMegan Fitzpatrick, Mythili P Pathipati, Kathy McCarty, et al.
Ugeskrift for Laeger|May 14, 2020
[Suspected toxoplasmosis in pregnancy]Mathilde Ørbæk, Anna Sophie L Kjær, Henrik V Nielsen, et al.
Pageof 88